Monte Rosa Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 10.39, indicating more challenging environment then in the fourth quarter 2025, but still, it is a far cry from any concerns. Monte Rosa Therapeutics Inc 's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 35 days, from 10 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 477 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 2364 to 3140.

What is Receivable Turnover Ratio?
What is Monte Rosa Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GLUE Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	227.34 %	2558.96 %	734.45 %	-75.92 %	134.28 %
Y / Y Revenue Change	-95.04 %	-95.41 %	38.54 %	394.01 %	7882.05 %
Receivable Turnover Ratio (TTM)	10.39	37.07	81.44	156.61	53.08
GLUE's Total Ranking	# 3140	# 2364	# 2068	# 1886	# 251
Accounts Receivable average collection period days	35	10	4	2	7
Seq. Receivable Change	0.2 %	-7.35 %	109.49 %	68.32 %	713.87 %
Seq. Revenue Change	51.38 %	-78.22 %	-44.95 %	-72.69 %	40.04 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 50
Healthcare Sector	# 478
Overall Market	# 3140

Receivable Turnover Ratio Statistics
High	Average	Low
0.47	0.32	0.09
(Jun 30 2025)		(Mar 31 2026)

GLUE Company Profile • Back to GLUE Efficiency Comparisons • Compare GLUE Receivables Turnover Ratio to its Competitors

Financial Statements
Monte Rosa Therapeutics Inc 's Accounts Receivable	$ 5 Millions	Visit GLUE's Balance sheet
Monte Rosa Therapeutics Inc 's Sales TTM	$ 43 Millions	Visit GLUE's Income Statement
Sources of GLUE's Revenues		Visit GLUE's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GLUE's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GLUE's Growth Rates	GLUE's Roa	GLUE's Inventory Turnover Ratio	GLUE's Dividend Comparisons
GLUE's Profitability Ratios	GLUE's Roi	GLUE's Asset Turnover Ratio	GLUE's Dividend Growth
GLUE's Valuation Ratios	GLUE's Roe	GLUE's Financial Strength Ratios	GLUE's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Biorestorative Therapies Inc	25.41	$ 0.363 Millions	$ 0.014 Millions
Jaguar Health Inc	24.65	$ 29.569 Millions	$ 1.200 Millions
Kiniksa Pharmaceuticals International Plc	24.63	$ 754.045 Millions	$ 30.618 Millions
Polomar Health Services, Inc.	24.47	$ 1.649 Millions	$ 0.067 Millions
Agenus Inc	24.33	$ 123.866 Millions	$ 5.091 Millions
Igc Pharma Inc	23.44	$ 1.166 Millions	$ 0.050 Millions
Cytomx Therapeutics Inc	23.09	$ 35.542 Millions	$ 1.539 Millions
Siga Technologies Inc	22.41	$ 93.777 Millions	$ 4.186 Millions
Lipocine Inc	22.09	$ 2.002 Millions	$ 0.091 Millions
Ataibeckley Inc	21.56	$ 3.488 Millions	$ 0.162 Millions
Fonar Corporation	21.15	$ 105.338 Millions	$ 4.981 Millions
Neuraxis Inc	20.94	$ 4.282 Millions	$ 0.204 Millions
Vystar Corporation	20.58	$ 0.048 Millions	$ 0.002 Millions
Lifemd Inc	19.91	$ 177.869 Millions	$ 8.934 Millions
Longeveron Inc	19.07	$ 1.216 Millions	$ 0.064 Millions
Sonida Senior Living Inc	18.82	$ 411.850 Millions	$ 21.878 Millions
Nutriband Inc	16.79	$ 1.803 Millions	$ 0.107 Millions
Bioadaptives Inc	16.64	$ 0.024 Millions	$ 0.001 Millions
Premier Air Charter Holdings Inc	16.33	$ 33.205 Millions	$ 2.033 Millions
Bioage Labs Inc	15.90	$ 10.316 Millions	$ 0.649 Millions
Escalon Medical Corp	15.15	$ 11.445 Millions	$ 0.756 Millions
Nurix Therapeutics Inc	15.11	$ 71.779 Millions	$ 4.750 Millions
Rosecliff Acquisition Corp I	15.05	$ 23.433 Millions	$ 1.557 Millions
Lexicon Pharmaceuticals Inc	14.91	$ 69.643 Millions	$ 4.670 Millions
Qhslab Inc	14.80	$ 2.775 Millions	$ 0.188 Millions
Nexgel Inc	14.19	$ 10.382 Millions	$ 0.732 Millions
Sutro Biopharma Inc	14.04	$ 99.608 Millions	$ 7.095 Millions
Precipio inc	13.93	$ 25.831 Millions	$ 1.854 Millions
China Pharma Holdings Inc	13.86	$ 3.992 Millions	$ 0.288 Millions
Talkspace Inc	13.67	$ 239.269 Millions	$ 17.501 Millions

Date modified: 2026-08-30T15:02:21+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.